High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients

Karin van den Hurk, Balazs Balint, Sinead Toomey, Patrick C. O'Leary, Louise Unwin, Kieran Sheahan, Enda W. McDermott, Ian Murphy, Joost J. van den Oord, Mairin Rafferty, Dara M. FitzGerald, Julie Moran, Robert Cummins, Owen MacEneaney, Elaine W. Kay, Cathal P. O'Brien, Stephen P. Finn, Cynthia C. B. B. Heffron, Michelle Murphy, Ruben YelaDerek G. Power, Padraic J. Regan, Clodagh M. McDermott, Allan O'Keeffe, Zsolt Orosz, Paul P. Donnellan, John P. Crown, Bryan T. Hennessy, William M. Gallagher*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)189-199
JournalMelanoma Research
Volume25
Issue number3
DOIs
Publication statusPublished - Jun 2015

Keywords

  • BRAF
  • genetics
  • genotyping
  • melanoma
  • MET
  • mutation profiling
  • PIK3R1

Cite this